SphingoGene, Inc.
PrivateCompany Overview
SphingoGene, Inc. is a biotechnology company that develops small molecule therapeutics for cancer treatment by targeting sphingolipid metabolism.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
biotechnologydrug discoverycancer therapeuticsoncologysmall molecule inhibitorssphingolipid metabolismacid ceramidaseASAH1biotech startuppreclinical researchchemotherapy resistancedrug developmentbiotechtherapeutics
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SphingoGene, Inc. Comparables
Compare SphingoGene, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CerRx | 81% | |
| Lipo-Immuno Tech | 80% | |
| Pendrea Bio, Inc. | 80% | |
SphingoGene, Inc. Funding Rounds
Historical fundraising activity
SphingoGene, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SphingoGene, Inc.'s valuation, stock price, and market status.
Firmographic Details
HeadquartersMount Pleasant, South Carolina
Year Founded2006
Last Funding—
See something wrong or outdated?